Yin C.  Becker net worth and biography

Yin Becker Biography and Net Worth

VP of Stryker

As vice president, chief corporate affairs officer, Yin is responsible for developing and implementing company level communication, marketing, government affairs and corporate responsibility strategies that grow and strengthen our position as a medical technology leader.

Yin has held multiple leadership roles within Stryker, including more than 20 years with the orthopaedics division, where she served as vice president, healthcare innovations and executive director of the Homer Stryker Center, in addition to leadership roles in sales services. Her team developed strategic business solutions, medical and sales education programs and award-winning patient awareness campaigns. She also launched the company's first global volunteerism and giving program and actively supports medical missions for underserved patients around the world.

Prior to joining us, Yin spent ten years with Pfizer, Inc. in various marketing and education leadership roles. She holds a bachelor’s degree in Psychology from Rider University.

What is Yin C. Becker's net worth?

The estimated net worth of Yin C. Becker is at least $6.38 million as of March 21st, 2019. Ms. Becker owns 16,577 shares of Stryker stock worth more than $6,379,658 as of November 23rd. This net worth approximation does not reflect any other assets that Ms. Becker may own. Learn More about Yin C. Becker's net worth.

How do I contact Yin C. Becker?

The corporate mailing address for Ms. Becker and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Yin C. Becker's contact information.

Has Yin C. Becker been buying or selling shares of Stryker?

Yin C. Becker has not been actively trading shares of Stryker during the past quarter. Most recently, Yin C. Becker sold 15,240 shares of the business's stock in a transaction on Thursday, March 21st. The shares were sold at an average price of $198.03, for a transaction totalling $3,017,977.20. Following the completion of the sale, the vice president now directly owns 16,577 shares of the company's stock, valued at $3,282,743.31. Learn More on Yin C. Becker's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (Chair and CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 10 times. They sold a total of 490,063 shares worth more than $165,955,919.20. The most recent insider tranaction occured on November, 7th when CEO Kevin Lobo sold 57,313 shares worth more than $21,131,303.10. Insiders at Stryker own 5.9% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/7/2024.

Yin C. Becker Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/21/2019Sell15,240$198.03$3,017,977.2016,577View SEC Filing Icon  
3/22/2018Sell3,848$162.90$626,839.2014,641View SEC Filing Icon  
3/9/2018Sell23,221$165.96$3,853,757.1610,499View SEC Filing Icon  
2/15/2017Sell4,398$125.27$550,937.4612,541View SEC Filing Icon  
1/4/2017Sell11,660$120.22$1,401,765.2028,599View SEC Filing Icon  
10/12/2016Sell12,000$114.03$1,368,360.0028,939View SEC Filing Icon  
10/6/2016Sell1,111$117.00$129,987.0016,939View SEC Filing Icon  
See Full Table

Yin C. Becker Buying and Selling Activity at Stryker

This chart shows Yin C Becker's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $384.85
Low: $381.48
High: $391.07

50 Day Range

MA: $366.20
Low: $345.14
High: $390.08

2 Week Range

Now: $384.85
Low: $285.79
High: $398.20

Volume

1,069,692 shs

Average Volume

1,498,897 shs

Market Capitalization

$146.71 billion

P/E Ratio

41.25

Dividend Yield

0.82%

Beta

0.91